Therefore, we recommend that patients with COPD who also have diabetes, high BP, dyslipidemia, or reduced fasting glucose levels begin using insulin, lipid-lowering medications, and oral hypoglycemic medications. The gene discussed is INS; the disease is chronic obstructive pulmonary disease.